|
AKTS Aktis Oncology Inc 2035832 |
| Balance Sheet |
|
Current Assets
|
$524,539,000.00 |
|
Assets
|
$557,596,000.00 |
|
Current Liabilities
|
$32,128,000.00 |
|
Liabilities
|
$72,758,000.00 |
|
Equity
|
$484,838,000.00 |
|
Shares Out
|
53446222.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,829,000.00 |
|
Investing Cash Flow
|
$-248,167,000.00 |
| Market Analysis |
Market Cap
|
$1,282,709,328.00 |
|
Price
|
$21.88 |
|
BVPS
|
9.07 |
|
PB
|
2.65 |
|
EPS
|
-0.44 |
|
PS
|
94.76 |
|
FCF
|
$-47,945,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:23 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AKTS documents filed with the SEC.
AKTS Filings
Clear
